{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:43:15Z","timestamp":1768711395184,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s43441-020-00198-0","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T14:02:43Z","timestamp":1594648963000},"page":"138-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?"],"prefix":"10.1007","volume":"55","author":[{"given":"Matthew J.","family":"Coleshill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eindra","family":"Aung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane E.","family":"Carland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Faasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-6937","authenticated-orcid":false,"given":"Richard O.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"issue":"11","key":"198_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"198_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10067-009-1362-1","volume":"29","author":"KJ Dirken-Heukensfeldt","year":"2010","unstructured":"Dirken-Heukensfeldt KJ, Teunissen T, Van de Lisdonk E, Lagro-Janssen A. Clinical features of women with gout arthritis. A systematic review. Clin Rheumatol. 2010;29(6):575\u201382.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"198_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1477-7525-10-117","volume":"10","author":"PP Khanna","year":"2012","unstructured":"Khanna PP, Nuki G, Bardin T, Tausche A-K, Forsythe A, Goren A, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey. Health Qual Life Outcomes. 2012;10(1):117.","journal-title":"Health Qual Life Outcomes."},{"issue":"3","key":"198_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.bor.0000157041.12116.69","volume":"17","author":"N Dalbeth","year":"2005","unstructured":"Dalbeth N, Haskard DO. Inflammation and tissue damage in crystal deposition diseases. Curr Opin Rheumatol. 2005;17(3):314\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"198_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/acr.20570","volume":"63","author":"N Dalbeth","year":"2011","unstructured":"Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, et al. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res. 2011;63(11):1605\u201312.","journal-title":"Arthritis Care Res."},{"issue":"6","key":"198_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3899\/jrheum.080814","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, MacDONALD PA, Lloyd E, Lademacher C. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol. 2009;36(6):1273\u201382.","journal-title":"J Rheumatol"},{"issue":"4","key":"198_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"198_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437\u201343.","journal-title":"Pharmacotherapy."},{"key":"198_CR9","doi-asserted-by":"crossref","unstructured":"Scheepers LE, van Onna M, Stehouwer CD, Singh JA, Arts IC, Boonen A, editors. Medication adherence among patients with gout: a systematic review and meta-analysis. In: Seminars in arthritis and rheumatism; 2018.","DOI":"10.1016\/j.semarthrit.2017.09.007"},{"issue":"S1","key":"198_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar1906","volume":"8","author":"G Nuki","year":"2006","unstructured":"Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8(S1):S1.","journal-title":"Arthritis Res Ther."},{"issue":"11","key":"198_CR11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","volume":"71","author":"M Doherty","year":"2012","unstructured":"Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, et al. Gout: why is this curable disease so seldom cured? Ann Rheum Dis. 2012;71(11):1765\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"198_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","volume":"14","author":"TJ Major","year":"2018","unstructured":"Major TJ, Dalbeth N, Stahl EA, Merriman TR. An update on the genetics of hyperuricaemia and gout. Nat Rev Rheumatol. 2018;14(6):341\u201353.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"198_CR13","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","volume":"71","author":"K Spencer","year":"2012","unstructured":"Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012;71(9):1490\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"198_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RHU.0b013e318204a8f9","volume":"17","author":"K Lindsay","year":"2011","unstructured":"Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011;17(1):1\u20136.","journal-title":"J Clin Rheumatol."},{"issue":"1","key":"198_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/acr2.11095","volume":"2","author":"M Kleinst\u00e4uber","year":"2020","unstructured":"Kleinst\u00e4uber M, Wolf L, Jones AS, Dalbeth N, Petrie KJ. Internalized and anticipated stigmatization in patients with gout. ACR Open Rheumatol. 2020;2(1):11\u20137.","journal-title":"ACR Open Rheumatol."},{"issue":"5","key":"198_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10067-015-3039-2","volume":"35","author":"P Chandratre","year":"2016","unstructured":"Chandratre P, Mallen CD, Roddy E, Liddle J, Richardson J. \u201cYou want to get on with the rest of your life\u201d: a qualitative study of health-related quality of life in gout. Clin Rheumatol. 2016;35(5):1197\u2013205.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"198_CR17","doi-asserted-by":"publisher","first-page":"e008323","DOI":"10.1136\/bmjopen-2015-008323","volume":"5","author":"J Liddle","year":"2015","unstructured":"Liddle J, Roddy E, Mallen CD, Hider SL, Prinjha S, Ziebland S, et al. Mapping patients\u2019 experiences from initial symptoms to gout diagnosis: a qualitative exploration. BMJ Open. 2015;5(9):e008323.","journal-title":"BMJ Open"},{"issue":"7","key":"198_CR18","first-page":"1350","volume":"29","author":"AG Fam","year":"2002","unstructured":"Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002;29(7):1350\u20135.","journal-title":"J Rheumatol"},{"issue":"2","key":"198_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.casemgr.2005.01.009","volume":"16","author":"JJ Vlasnik","year":"2005","unstructured":"Vlasnik JJ, Aliotta SL, DeLor B. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager. 2005;16(2):47\u201351.","journal-title":"Case Manager."},{"issue":"1","key":"198_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4081\/reumatismo.2020.1227","volume":"72","author":"L Punzi","year":"2020","unstructured":"Punzi L, Medea G. Understanding and perceptions of gout: an interdisciplinary assessment among patients, physicians and pharmacists in Italy. Reumatismo. 2020;72(1):31\u201343.","journal-title":"Reumatismo."},{"issue":"1","key":"198_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3899\/jrheum.150607","volume":"43","author":"S Vaccher","year":"2016","unstructured":"Vaccher S, Kannangara DR, Baysari MT, Reath J, Zwar N, Williams KM, et al. Barriers to care in gout: from prescriber to patient. J Rheumatol. 2016;43(1):144\u20139.","journal-title":"J Rheumatol"},{"issue":"4","key":"198_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1185\/03007995.2011.552570","volume":"27","author":"BJ Pandya","year":"2011","unstructured":"Pandya BJ, Riedel AA, Swindle JP, Becker LK, Hariri A, Dabbous O, Krishnan E. Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings. Curr Med Res Opin. 2011;27(4):737\u201344.","journal-title":"Curr Med Res Opin."},{"issue":"5","key":"198_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Care Res. 2007;57(5):822\u20139.","journal-title":"Arthritis Care Res."},{"issue":"10156","key":"198_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","volume":"392","author":"M Doherty","year":"2018","unstructured":"Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, et al. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial. The Lancet. 2018;392(10156):1403\u201312.","journal-title":"The Lancet."},{"issue":"3","key":"198_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-234","volume":"20","author":"R Goldfien","year":"2016","unstructured":"Goldfien R, Pressman A, Jacobson A, Ng M, Avins A. A pharmacist-staffed, virtual gout management clinic for achieving target serum uric acid levels: a randomized clinical trial. Permanente J. 2016;20(3):15\u2013234.","journal-title":"Permanente J."},{"issue":"3","key":"198_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1172\/JCI109523","volume":"64","author":"I Spilberg","year":"1979","unstructured":"Spilberg I, Mandell B, Mehta J, Simchowitz L, Rosenberg D. Mechanism of action of colchicine in acute urate crystal-induced arthritis. J Clin Investig. 1979;64(3):775\u201380.","journal-title":"J Clin Investig."},{"issue":"1","key":"198_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1037\/hea0000548","volume":"37","author":"KJ Petrie","year":"2018","unstructured":"Petrie KJ, MacKrill K, Derksen C, Dalbeth N. An illness by any other name: the effect of renaming gout on illness and treatment perceptions. Health Psychol. 2018;37(1):37.","journal-title":"Health Psychol"},{"issue":"5","key":"198_CR28","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.28140","volume":"62","author":"U Beuers","year":"2015","unstructured":"Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, et al. Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019. Hepatology. 2015;62(5):1620\u20132.","journal-title":"Hepatology"},{"issue":"12","key":"198_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrgastro.2015.187","volume":"12","author":"PJ Trivedi","year":"2015","unstructured":"Trivedi PJ, Hirschfield GM. Primary biliary cirrhosis: renaming primary biliary cirrhosis\u2014clarity or confusion? Nat Rev Gastroenterol Hepatol. 2015;12(12):678\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1\u20133","key":"198_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.schres.2015.01.031","volume":"162","author":"A Lasalvia","year":"2015","unstructured":"Lasalvia A, Penta E, Sartorius N, Henderson S. Should the label\u201d schizophrenia\u201d be abandoned? Schizophrenia Res. 2015;162(1\u20133):276\u201384.","journal-title":"Schizophrenia Res."},{"issue":"2","key":"198_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/schbul\/sbt231","volume":"40","author":"N Sartorius","year":"2014","unstructured":"Sartorius N, Chiu H, Heok KE, Lee M-S, Ouyang W-C, Sato M, et al. Name change for schizophrenia. Schizophrenia Bull. 2014;40(2):255.","journal-title":"Schizophrenia Bull."},{"issue":"1","key":"198_CR32","first-page":"53","volume":"5","author":"M Sato","year":"2006","unstructured":"Sato M. Renaming schizophrenia: a Japanese perspective. World Psychiatry. 2006;5(1):53.","journal-title":"World Psychiatry."},{"issue":"10","key":"198_CR33","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00127-015-1064-8","volume":"50","author":"S Koike","year":"2015","unstructured":"Koike S, Yamaguchi S, Ojio Y, Shimada T, Watanabe K-I, Ando S. Long-term effect of a name change for schizophrenia on reducing stigma. Soc Psychiatry Psychiatr Epidemiol. 2015;50(10):1519\u201326.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"}],"container-title":["Therapeutic Innovation &amp; Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-020-00198-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-020-00198-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-020-00198-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T23:05:16Z","timestamp":1626131116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-020-00198-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s43441-020-00198-0","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}